You are now viewing 1 - 10 of 28 results
September 1, 2011 | Journal Article
Using market exclusivity to promote pharmaceutical innovation can lead to positive outcomes, but the practice is also characterized by waste and collateral effects.
June 21, 2012 | Journal Article
Biomarkers may prove important in medicine, but controversy about biomarker patents has increased in recent years.
May 1, 2013 | Journal Article
Tobacco control endgame strategies threaten to create large black markets with potential attendant harms.
May 1, 2013 | Journal Article
Establishing performance standards for tobacco products is just one tool to reduce the death and disease caused by the use of these products.
May 1, 2013 | Journal Article
Interest in reducing or eliminating tobacco-caused diseases is a common goal in tobacco control, but many experts hold different views on addition as a target of intervention.
March 14, 2011 | Journal Article
The authors suggest repairing the health care system by realigning provider incentives, increasing the availability of information with which consumers can make health care decisions and creating public tools to enforce provider competition based on cost and quality of care.
January 11, 2010 | Journal Article
The 2005 US Food and Drug Administration (FDA) "black box" advisory warning that atypical antipsychotic drugs increased risk of death with elderly patients with dementia led to fewer mentions of the drugs by physicians in the four years after implementation of the drug label requirement.
May 1, 2013 | Journal Article
This article assesses the structural choices for the proposed tobacco endgame strategies.
May 1, 2013 | Journal Article
Most smokers have been able to stop smoking without any formal assistance such as medication or professional assistance.
January 1, 2010 | Journal Article
The medical profession and pharmaceutical industry have fallen short in reducing the influence of gifts on prescription practices through self-regulation. This commentary describes efforts at self-regulation by the pharmaceutical industry and the medical profession.